Management is buying/committing capital at a price it says the market itself just set against it — cheapness measured ag
The model's full reasoning — Q1 2018 call → NOWe need to determine if management describes deliberately taking on more of its own economic exposure because it believes the outside world is mispricing what it already has. The question asks for a specific posture: management asserts that the value assigned to the company or its assets is materially below what it's worth, anchored to something concrete, and the company is acting on it with real resources already in motion. Looking at the transcript, management discusses their strategies, including improving profitability, innovating products, expanding e-commerce, and transforming the business model. They talk about New World Fossil initiatives, cost savings, and margin improvements. They mention that they are planning prudently but operating aggressively. They discuss wearables growth and traditional watch declines. They talk about store closures and business exits. They mention that they are focused on near-term profitability and that they expect sales to stabilize in 2019 and grow in 2020. There is no mention of the company buying back shares, acquiring assets, or taking on more exposure because they believe the market is undervaluing them. They do not discuss any specific mispricing of their assets or shares. They do not mention any concrete benchmark like comparable transactions or replacement costs. They do not say that outsiders are valuing the company too low. They express confidence in their strategies and long-term prospects, but that is not the same as asserting a mispricing and acting on it. The question requires both halves: (1) a mispricing claim anchored to something concrete, and (2) the company acting on it with real resources. Neither is present. Management talks about improving profitability and transforming the business, but not about buying back stock or acquiring assets because they are undervalued. They mention store closures and business exits, which are shedding exposure, not taking on more. Thus, the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CTHR | Charles & Colvard, Ltd. | Q1 2023 | 2022-11-06 | F |
| SBGI | Sinclair Broadcast Group, Inc. | Q3 2022 | 2022-11-02 | C |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
TWO · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the mispricing to concrete, verifiable levels: mortgage spreads at “historically wide” levels (125–150 bp ZV/OAS, far above the non-QE average and the March 31 levels), RMBS coupons now trading at a wide range (2 %–5.5 %) with 300 bp “out-of-the-money” low-coupon pools and 97 bp OAS–ZV spread differential on higher-coupon names.
ESEA · Q4 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete, verifiable figure: their own estimate of the fleet’s market value at $666 million (derived from charter-adjusted values and market changes, incorporating the Aegean Express incident), which produces a net asset value of $344 million or >$48 per share.
WD · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete benchmark: CoStar trades at ~30x EBITDA while W&D trades at under 10x despite identical revenue and EBITDA growth rates over 5–10 years. They explicitly state there is “plenty of multiple expansion available to W&D.